SMTL ID : 6zb1.1

C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH GSK620

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 4 residues within 4Å: Chain A: Q.103, D.104, E.107, F.108 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:D.104 EDO.2: 3 residues within 4Å: Chain A: Y.28, M.98, K.101 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:K.101

1 x QCZ: ~{N}5-cyclopropyl-~{N}3-methyl-2-oxidanylidene-1-(phenylmethyl)pyridine-3,5-dicarboxamide(Non-covalent)

QCZ.3: 11 residues within 4Å: Chain A: W.30, P.31, F.32, V.36, L.43, Y.88, N.89, P.90, H.93, V.95, M.98 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:W.30, A:P.31, A:L.43, A:Y.88, A:V.95, A:V.95 Hydrogen bonds: A:P.31, A:N.89, A:N.89 pi-Stacking: A:H.93

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Seal, J.T. et al., The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor. J.Med.Chem. (2020)

Release Date

2020-08-05

Peptides

Bromodomain-containing protein 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

Bromodomain-containing protein 2

Related Entries With Identical Sequence